Is There an Association Between GLP ‐ 1RA Use and Blood Cancer Incidence or Progression?
American Journal of Hematology · 13.11.2026
DOI: 10.1002/ajh.70552 ↗Kurz gefasst
Leserbrief in der Zeitschrift American Journal of Hematology, online erschienen am 13.11.2026. Verfasst von Hagop Kantarjian und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
- Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Hagop Kantarjian, Ayalew Tefferi
Zitieren
APA
Kantarjian, H., & Tefferi, A. (2026). Is There an Association Between GLP ‐ 1RA Use and Blood Cancer Incidence or Progression?. American Journal of Hematology. https://doi.org/10.1002/ajh.70552
Vancouver
Kantarjian H, Tefferi A. Is There an Association Between GLP ‐ 1RA Use and Blood Cancer Incidence or Progression?. American Journal of Hematology. 2026. doi:10.1002/ajh.70552
BibTeX
@article{Kantarjian2026,
author = {Kantarjian, Hagop and Tefferi, Ayalew},
title = {Is There an Association Between GLP ‐ 1RA Use and Blood Cancer Incidence or Progression?},
journal = {American Journal of Hematology},
year = {2026},
doi = {10.1002/ajh.70552}
}
EUVIMED